Euba B et al. |
Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712355
|
Shigemura K et al. |
Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712352
|
Imamura Y et al. |
Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328111
|
Soltow SM and Brenner GM |
Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060522
|
Solomon AW et al. |
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251338
|
Kirkcaldy RD et al. |
Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25451056
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Henry DC et al. |
Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12936972
|
Ohrt C et al. |
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121927
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Grinwis ME et al. |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20404127
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Schmalstieg AM et al. |
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22751536
|
Pandori MW et al. |
Detection of azithromycin resistance in Treponema pallidum by real-time PCR. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620374
|
Capobianco JO and Goldman RC |
Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H). |
1990 |
Antimicrob. Agents Chemother. |
pmid:2178338
|
Gorby GL and McGee ZA |
Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. |
1990 |
Antimicrob. Agents Chemother. |
pmid:1982402
|
Bonnet M and Van der Auwera P |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390808
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Kobuchi S et al. |
Transport of Azithromycin into Extravascular Space in Rats. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27600045
|
Goldman RC and Capobianco JO |
Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. |
1990 |
Antimicrob. Agents Chemother. |
pmid:1963291
|
Binet R et al. |
Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20065052
|
Mallegol J et al. |
Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24277019
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Edelstein PH and Edelstein MA |
In vitro activity of azithromycin against clinical isolates of Legionella species. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1849708
|
Ohara T et al. |
Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384353
|
Fuentes F et al. |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527796
|
Itaqui SR et al. |
In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27216049
|
Matic V et al. |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504828
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Beale AS and Upshon PA |
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811001
|
Berry V et al. |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835514
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Chisholm SA et al. |
High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585125
|
Tomazic J et al. |
Ex vivo effect of azithromycin in human leukocyte bactericidal functions. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486947
|
Ouyang-Latimer J et al. |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21115800
|
Deshpande D et al. |
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26810646
|
Vazifeh D et al. |
Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9333032
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Gunell M et al. |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20498312
|
Carvalho-Assef AP et al. |
Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24449772
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Roblin PM and Hammerschlag MR |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624507
|
Woosley LN et al. |
CEM-101 activity against Gram-positive organisms. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20176910
|
Pérez-MartÃnez I and Haas D |
Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21537014
|
Odenholt I et al. |
Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371360
|
Phillips-Campbell R et al. |
Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24342653
|